These results indicated that the effect of down‐regulation of caveola‐forming proteins may take time to appear and suggested the use of stable and complete ablation of CAV1 or CAVIN1 using CRISPR knockout GBM cells. The gene discussed is CAV1; the disease is glioblastoma.